A screen displays the logo and trading information for Humana on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., December 6, 2023. REUTERS/Brendan McDermid

(Reuters) -Humana said on Wednesday about 83% of stand-alone prescription drug plans for 2026 will offer a premium decrease.

The health insurer said it expects more than 80% of its Medicare Advantage members will be in plans with stable benefits.

(Reporting by Mariam Sunny in Bengaluru; Editing by Shailesh Kuber)